-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Chemours, Lowers Price Target to $22

Benzinga·08/06/2026 17:54:51
Listen to the news
RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $26 to $22.